Médecins Sans Frontières

Pioneering new MSF-run clinical trial for drug-resistant TB treatment starts

A pioneering new clinical trial aiming to find a radically improved course of treatment for drug-resistant tuberculosis (TB) began on 17th January 2017, when the first patient took the first pill in Uzbekistan.

Read More →

MSF calls on Johnson & Johnson to improve access to bedaquiline

Médecins Sans Frontières (MSF) urges Johnson & Johnson to ensure widespread access to bedaquiline for the treatment of multidrug-resistant TB.

Read More →

MSF and Stop TB Partnership urge further action to address TB crisis at BRICS health meeting

Geneva, 16 December 2016

Read More →

MSF urges the Global Fund to freeze implementation of transition plans

Médecins Sans Frontières (MSF) expressed concerns about the Global Fund’s policies on allocation, co-financing, and transition.

Read More →

Tajikistan: Stories from MSF's paediatric TB projects

Delamanid is one of the first new TB medicines in over 50 years, and recently the project team in Dushanbe, Tajikistan's capital, started treating a young TB patient with it. It follows several months of preparations and negotiations with the Ministry of Health and its counterparts.

Read More →

India: New drugs, new hope

Two new drugs, bedaquiline and delamanid, are proving to be the very last life-line for TB patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able to access them as they are not widely available.

Read More →

MSF reports on use of the new TB drugs bedaquiline and delamanid

Access to the new TB drugs remains severely limited worldwide, but MSF hopes its experience can inform and encourage wider use, while needed clinical research continue.

Read More →

How one organisation is helping Indians with extremely drug-resistant TB get the help they need

An article published in the Better India describes what Médecins Sans Frontières does for patients with extremely drug-resistant TB in India. The article is about one of those patients in Mumbai. Click here to read it and watch a short video.

Read More →

MSF general statement at the 56th Series of WIPO Assembly

Médecins Sans Frontières (MSF) would like to urge WIPO and its member states to tackle the on-going challenges of spiralling drug prices and neglect of public health priorities in the IP-driven medical innovation system.

Read More →

As U.N. General Assembly starts, MSF urges governments to set medical research policies that align with people’s health needs

New MSF report exposes pharma industry failings and highlights new ways of researching and developing medicines that address public health needs.

Read More →

Page 2 of 4 · Total posts: 10

←First 1 2 3 Last→